Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: A cohort study-Reference-Cited by-同舟云学术

Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: A cohort study

Published:2011-04 Issue:2 Volume:26 Page:193-200
ISSN:0883-9441
Container-title:Journal of Critical Care
language:en
Short-container-title:Journal of Critical Care

Author:

Salluh Jorge I.F.,Soares Márcio,Coelho Luis M.,Bozza Fernando A.,Verdeal Juan Carlos R.,Castro-Faria-Neto Hugo C.,Silva José Roberto Lapa e,Bozza Patrícia T.,Póvoa Pedro

Publisher

Elsevier BV

Subject

Critical Care and Intensive Care Medicine

Reference31 articles.

1. Recent advances in community-acquired pneumonia: inpatient and outpatient;Niederman;Chest,2007

2. BTS guidelines for the management of community acquired pneumonia in adults: update 2009;Lim;Thorax,2009

3. Intensive care and emergency medicine: progress over the past 25 years;Vincent;Chest,2006

4. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults;Mandell;Clin Infect Dis,2007

5. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock;Rodriguez;Crit Care Med,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in pulmonary infections: a clinical approach;Annals of Intensive Care;2024-07-17

2. The ARREST Pneumonia Clinical Trial. Rationale and Design;Annals of the American Thoracic Society;2021-04

3. When should we use corticosteroids in severe community-acquired pneumonia?;Current Opinion in Infectious Diseases;2020-12-29

4. The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design;Annals of the American Thoracic Society;2020-07

5. Use of glucocorticoids in the critical care setting: Science and clinical evidence;Pharmacology & Therapeutics;2020-02